View Post

Easy-to-Read Medication Guide for Patients Proposed

In COVID-19, Latest News by Precision Vaccinations

The U.S. Food and Drug (FDA) Commissioner Robert M. Califf, M.D., today issued the following statement 'Providing people with accurate and timely information to help them take their prescription medications safely and effectively is an essential priority for the FDA.
And evidence suggests that more easy-to-read information can help patients reduce preventable adverse drug reactions and improve health outcomes.

View Post

A Better But Not Perfect Polio Vaccine

In COVID-19, Latest News by Precision Vaccinations

The World Health Organization (WHO) Director-General recently convened the thirty-fifth meeting of the Emergency Committee under the International Health Regulations on the international spread of poliovirus.
On May 3, 2023, the Committee reviewed data on wild poliovirus (WPV1) and circulating vaccine-derived polioviruses (cVDPV) in the context of the global target of eradication of WPV and cessation of outbreaks of cVDPV2 by the end of 2023.

View Post

Controlling Meningococcal Disease with Innovative Vaccines

In COVID-19, Latest News by Precision Vaccinations

The human pathogen Neisseria meningitidis has been feared worldwide for more than 215 years and has caused epidemics, pandemics, and sporadic cases of meningitis, fatal sepsis, and, less commonly, pneumonia, wrote David S. Stephens, M.D. in an Editorial published by the New England Journal of Medicine.
Although disease rates have decreased in many regions partly due to the introduction of highly effective vaccines, Neisseria meningitidis case fatality remains high at 10 to 20%.

View Post

Smallpox Vaccination Effective Against Mpox

In COVID-19, Latest News by Precision Vaccinations

Researchers from Karolinska Institutet recently reported vaccines used against smallpox given until the mid-1970s offer continuing cross-reactive immunity to mpox.
A study published in the scientific journal Cell Host & Microbe on April 25, 2023, reports robust effector memory MPXV-specific T cell responses in mild mpox and long-lived TCF-1+ VACV/MPXV-specific CD8+ T cells decades after smallpox vaccination.

View Post

Oral Gonorrhea Treatment Study Proceeds

In COVID-19, Latest News by Precision Vaccinations

Without an approved vaccine preventing gonorrhea infections, there is significant demand for innovative treatments for millions of people each year.
To meet that need, the Global Antibiotic Research & Development Partnership (GARDP) and Innoviva Specialty Therapeutics today announced the completion of recruitment for their global phase 3 pivotal registration trial of oral zoliflodacin, an investigational, first-in-class antibiotic being developed for the treatment of uncomplicated gonorrhoea infection in patients.

View Post

Old Vaccine Associated with a Significantly Lower Rate and Risk of Alzheimer Disease and Related Dementias

In COVID-19, Latest News by Precision Vaccinations

A recent study conducted in Boston, MA, found patients appear to live longer and have a reduced incidence of Alzheimer's disease and related dementias (ADRD) after BCG vaccine treatment. 
This Original Investigation was published by the peer-review journal The JAMA Network Open on May 19, 2023, and found the 100-year-old Bacillus Calmette-Guérin (BCG) vaccine was associated with a reduced risk of Alzheimer's disease and related dementias.